Trials / Terminated
TerminatedNCT01170468
Does Vitamin D Reduce Risk of Developing Type II DM in High Risk Individuals
Does Vitamin D Reduce Risk of Developing Type II DM in Prediabetics? A Double Blind Randomized Controlled Trial
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 25 (actual)
- Sponsor
- King Faisal Specialist Hospital & Research Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
Both vitamin D deficiency and type II DM/prediabetes are highly prevalent. Vitamin D status has been negatively associated with the presence of type II DM and glycemic control. A cause-effect relationship between vitamin D deficiency and the development of type II DM has not been established. The investigators plan to conduct a 2 year, double blind, randomized, placebo controlled trial on the effect of vitamin D3 supplement on the incidence of type II DM in high risk individuals.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Vitamin D3 | Vitamin D3 5000 IU orally, daily for 2 years |
| DRUG | Placebo | Placebo orally, daily for 2 years |
Timeline
- Start date
- 2011-12-01
- Primary completion
- 2014-01-15
- Completion
- 2014-01-15
- First posted
- 2010-07-27
- Last updated
- 2018-03-07
Locations
1 site across 1 country: Saudi Arabia
Source: ClinicalTrials.gov record NCT01170468. Inclusion in this directory is not an endorsement.